The nutritional management of infants with bronchopulmonary dysplasia (BPD) is a challenge for the clinician due to numerous factors that affect the provision and utilization of nutrients. Factors such as greater energy expenditure, [1] [2] [3] [4] diuretic therapy, 5, 6 and fluid restriction, 7 become major problems because they compromise growth, the optimal therapy for these infants. 8, 9 Twenty-four calorie per ounce preterm formulas originally were designed to meet the needs of the growing healthy premature infant when administered at a volume of ϳ150 ml/kg per day. When the respiratory management of an infant with BPD requires fluid restriction, modular nutrient components added to preterm formulas improve energy and protein intake but may compromise the overall nutrient integrity of the formula, 10 increase its osmolality, 10, 11 and dilute the mineral and micronutrient components of the formula. The American Academy of Pediatrics recommends that formulas for normal infants have concentrations of no greater than 450 mOsm/kg H 2 O. 12 Several institutions also use routine powdered infant formula or infant formula concentrate mixed with preterm formula to enhance nutrient intake. These enteral nutrient admixtures also may adhere to the feeding tube and bottle, decrease milk flow through small caliber feeding tubes, and diminish nutrient delivery to the infant. 10 To avoid the use of enteral admixtures, we evaluated a ready-tofeed formula in the management of older premature infants with BPD. The purpose of this pilot study was to evaluate growth, feeding tolerance, and the potential for nutrient inadequacies in premature infants with BPD fed either a ready-to-feed formula or a preterm formula containing a variety of nutrient supplements.
METHODS
This review describes how two enteral formulas were used in our nurseries. Permission to review patient records was approved by the Institutional Review Board for Human Subject Research of Baylor College of Medicine (Houston, TX). All subjects were newborn infants admitted to the neonatal intensive care unit at Texas Children's Hospital between 1994 and 1998. Infants with a diagnosis of BPD, a persistent oxygen requirement beyond 28 days of age with compatible chest radiographic changes, 13 who were fed commercial formula and treated with a fluid restriction of Յ130 ml/kg per day were followed longitudinally throughout their hospital course by the Neonatal Nutrition Team. Initially, all infants were fed 24 kcal/oz preterm formula with iron (Enfamil Premature Formula; Mead Johnson Nutri-
tionals, Evansville, IN) at 150 ml/kg per day. When fluid restriction was initiated, infants were given the preterm formula plus glucose polymers (Polycose; Ross Products Division, Abbott Laboratories, Columbus, OH) usually prepared to 27 kcal/oz and individual doses of corn oil (ϳ2 ml/kg per day) calculated to provide a milk concentration of Ն30 kcal/oz (Table 1) . Ultimately, at the discretion of the attending neonatologist, a subgroup of these infants was given a ready-to-feed 30 kcal/oz formula (PediaSure; Ross Products Division, Abbott Laboratories). The ready-to-feed formula was used after the infant had attained a chronological age of 4 months or at Ն44 weeks postmenstrual age. The transition to the ready-to-feed formula was made by increasing the feedings by one feed per day as tolerated by the infant. The remaining infants were maintained on the preterm formula with additives. The two groups (group A, infants that eventually received the ready-to-feed formula; group B, infants that continued to receive the preterm formula with additives) were evaluated during three phases. In phase 1 (A1, B1), infants received 24 kcal/oz preterm formula with iron at 150 ml/kg per day. In phase 2 (A2, B2), all infants' fluids were restricted to Յ130 ml/kg per day using preterm formula with additives. In phase 3 (A3, B3), the infants received further fluid restriction provided as either the ready-to-feed formula (A3) or preterm formula with additives (B3).
Growth was evaluated weekly. Weight was measured daily to the nearest 1 gm using electronic scales (Model 4800, Scale Tronix, Wheaton, IL). Recumbent length, to the nearest 0.1 cm (O'Leary Newborn Length Board; Ellard Instrumentation, Seattle, WA) was measured at 36 weeks' postmenstrual age and monthly thereafter. Biochemical indicators of nutritional status, albumin, alkaline phosphatase activity, phosphorus, and blood urea nitrogen (BUN) were measured every other week throughout hospitalization. Fluid intake (type and amount), urine output, and indices of feeding tolerance were assessed daily. Overall fluid balance was assessed by daily intake and output, body weight changes, and the measurement of serum electrolytes twice weekly. Nutrient intake was analyzed for potential deficiencies using Neonova (Ross Products Division, Abbott Laboratories), a neonatal nutrition software program. Feeding tolerance was determined by a change in stool pattern, abdominal distention, a change in gastric residual volume, and/or emesis. The duration of therapy with diuretic, glucocorticoid, and antibiotic medications as well as number of infants receiving anti-gastroesophageal reflux medications were tabulated.
Statistical comparisons of clinical characteristics between groups were made using nonparametric methods. Statistical comparisons of intakes, growth, feeding tolerance, and biochemical indicators of nutritional status were made using repeated measures analysis of variance. Results demonstrating probability levels of Յ0.05 were considered significant. Unless indicated otherwise, the data were expressed as median and 25th and 75th percentiles.
RESULTS
A total of 27 infants with BPD requiring severe fluid restriction between November of 1994 and December of 1998 participated in this evaluation. In phase 3, 16 infants were switched from preterm formula to the ready-to-feed formula (A3) and 11 infants continued to receive a preterm formula plus additives (B3). The clinical character- istics of the 27 infants are shown in Table 2 . Group A was older and attained a greater body weight than group B when fluid restriction was initiated in phase 2. The duration of hospitalization also was longer for the infants in group A. The nutrition parameters for each treatment group and phase are shown in Tables 3 and 4 . There were no differences in fluid and milk intake between groups. However, milk intake decreased in both groups over time (Table 3) . Calorie, protein, and modular calorie intake were similar between groups. Modular protein intake increased over time for the infants in group C. Chloride supplementation was similar between groups. The tabulation of nutrient intakes indicated that group A, during phase A3, had marginal vitamin D intake. That group was given 1 ml per day of a multivitamin supplement (Poly-Vi-Sol, Ross Products Division, Abbott Laboratories). The number of infants requiring anti-gastroesophageal reflux medications did not differ between groups, but increased over time ( p Ͻ 0.05). Weight velocity was similar between groups, but increased over time. Linear growth was similar between groups and over time (Table 4 ). There were no differences in feeding tolerance between groups during any of the phases. The number of stools, however, was significantly more in group A compared with group B.
Biochemical indicators of protein nutritional status were improved in group A compared with group B (Table 4 ). There was a significant group-time interaction for BUN concentration. BUN was significantly greater in group A compared with group B during phase 3. Both serum phosphorus and alkaline phosphatase were similar between groups and over time.
DISCUSSION
Infants with BPD require greater energy and protein intakes 14 from balanced nutrition sources, while avoiding excessive mineral intake to decrease the risk of nephrocalcinosis. 15 The therapy for infants with BPD (steroids, 2,4 diuretics, 5, 6 and fluid restriction 7 ) also may compromise nutrition status. DeRegnier et al. 16 demonstrated that low protein and calorie diets in infants with BPD were associated with less arm fat and muscle accretion and slower growth at as early as 2 weeks of age when compared with premature infants that never developed BPD. In addition, when full enteral feeding was achieved, BPD infants had growth velocities that were similar to those of controls; however, these infants did not demonstrate catch-up growth. 16 Growth failure as a result of medical therapies, particularly fluid restriction, should not be an assumed outcome. The use of preterm formula with additives is a common therapy practiced out of necessity in many neonatal intensive care units for infants requiring fluid restriction. The benefit of using nutrient additives is to maintain uniform nutrient intakes to insure adequate growth in the chronically ill infant with BPD. One disadvantage of using only calorie additives (such as glucose polymers or fat), however, is that they may dilute the protein, mineral, and micronutrient content of the milk. In addition, nonprotein calorie additives may support weight gain due to fat accretion, but may not increase lean body mass proportionately. 17 The net effect of nutrient additives on absorption and/or the bioavailability of milk components has not been investigated. Several studies have shown that mix- Chloride supplement (mEq/kg per day)
*All infants received preterm formula with iron at 150 ml/kg per day. Group A received ready-to-feed formula and group B received preterm formula with additives. †All infants received preterm formula with additives at 130 ml/kg per day. Group A received ready-to-feed formula and group B received preterm formula with additives. ‡Further fluid restriction was imposed. Group A received ready-to-feed formula and group B received preterm formula with additives. Group designation was based on diet in phase 3. §Significant differences over time (phase 1 to phase 3), p ϭ 0.001; differences between groups were not significant. ¶Significant differences over time (phase 1 to phase 3), p Ͻ 0.005; interaction between groups, p ϭ 0.002. Significant difference between groups in phase 3, p ϭ 0.01.
ing fat with formula results in fat separation and adherence to feeding tubes. 18, 19 Saigal and Sinclair, 20 compared feeding a 20 kcal/oz formula with feeding a 30 kcal/oz formula to low birth weight infants. The only moderately adverse affect noted in that study was a higher urine osmolality in infants that were fed the 30 kcal/oz formula compared with those infants that were fed the 20 kcal/oz formula.
In contrast, we report the use of a ready-to-feed 30 kcal/oz formula that is well tolerated in older premature infants with BPD. We show that along with severe fluid restriction, less protein supplementation was needed over time in group A, and that the isosmolar readyto-feed formula supported the nutritional needs for this high-risk population. [21] [22] [23] Except for stool output, which differed but was not excessive, feeding tolerance was similar between groups. One infant developed watery stool output after the ready-to-feed formula was initiated. This was attributed to the inadvertent use of ready-to-feed formula containing fiber and to a rapid transition to all ready-to-feed formula.
Weight velocity between groups was similar, but there was a significant time effect. In both groups, weight patterns improved over time. This may be due to the decreasing energy needs of infants as they mature. Serum albumin concentrations were significantly higher in group A versus group B, owing to the higher protein content of the ready-to-feed formula. Serum albumin also improved over time, and this improvement may be associated with increased hepatic synthesis of albumin as an infant matures. Although BUN was higher in group A, it was within the accepted normal range; we speculate that this signifies an improved protein nutritional status. 24 The use of anti-reflux medications increased over time, but was not significantly different between groups. This finding concurs with a study by Radford et al. 25 that indicated that gastroesophageal reflux is more common in infants with BPD. An advantage of using a 30 kcal/oz formulation also may be the provision of a lower volume of milk while continuing to meet nutrient needs.
Fewtrell et al. 7 compared feeding a 30 kcal/oz formula (intake 145 ml and 145 kcal/kg per day) with feeding a preterm formula (intake 180 ml and 150 kcal/kg per day) in premature infants of Յ32 weeks' gestational age and Յ1500 gm. They hypothesized that the infants fed the 30 kcal/oz formula would have better growth than those fed the preterm formula. Although the group receiving the 30 kcal/oz formula was less healthy, feeding tolerance was similar; however, the 30 kcal/oz group required a shorter duration of diuretic therapy when compared with infants fed the 24 kcal/oz formula. Importantly, the investigation reported no differences between groups with regard to growth measures. Our results did not show a difference in the duration of diuretic therapy between groups because our infants were older and were hospitalized for a longer duration.
Other institutions use routine term formula to concentrate nutrients in preterm formula when fluid restriction is necessary. Reimers et al.
14 described the use of a combination of preterm and term formula in a ratio of 3:1. The osmolality was 388 mOsm/kg H 2 O compared with the lower osmolality (300 mOsm/kg H 2 O) of the read-to-feed formula used in our study. A comparison of the nutrient composition of the two formulations shows that the ready-to-feed formula we used had a higher protein and chloride content and more balanced nonprotein calories, which would be more favorable for the infant with BPD. Jew et al. 26 studied the osmolalities of the oral medications and formulas used in their nursery. Although no osmolalities for 30 kcal/oz formulas were reported in their study, the osmolalities for Pregestimil (Mead Johnson Nutritionals) and Enfamil Premature 24 mixed with Similac PM 60/40 (Ross Products Division, Abbott Laboratories) concentrated to 27 kcal/oz were 496 and 360 mOsm/kg H 2 O, *All infants received preterm formula with iron at 150 ml/kg per day. Group A received ready-to-feed formula and Group B received preterm formula with additives. †All infants received preterm formula with additives at 130 ml/kg per day. Group A received ready-to-feed formula and Group B received preterm formula with additives. ‡Further fluid restriction was imposed. Group A received ready-to-feed formula and Group B received preterm formula with additives. Group designation was based on diet in phase 3. §Significant differences over time (phase 1 to phase 3), p Ͻ 0.001; differences between groups not significant. ¶Significant differences between groups, p Ͻ 0.01. Significant differences over time (phase 1 to phase 3), p Ͻ 0.001; significant differences between groups, p Ͻ 0.01. #Significant interaction between group and time, p Ͻ 0.01. **Significant difference between groups during phase 3, p Ͻ 0.05. † †International units.
respectively. At these concentrations, the nutrient content is similar to the ready-to-feed formula we used, but the osmolalities are significantly greater. We demonstrated that a ready-to-feed formula provides a similar nutrient composition and nutritional status to preterm formula enhanced with multiple additives in premature infants with BPD. These results also show that ready-to-feed formula is a safe alternative compared with providing a concentrated term formula to infants with BPD requiring severe fluid restriction. Further study of the absorption and bioavailability of supplements added to formulas as well as their effects on body composition is warranted. We believe that the use of ready-to-feed formula in larger and older premature infants should be encouraged, because currently it is not approved for use in this population. There are other alternatives for providing nutrition to fluidrestricted infants. We recommend randomized clinical trials of readyto-feed 30 kcal/oz formulas and routine formula concentrated to 30 kcal/oz. These pilot data, however, indicate acceptance of the 30 kcal/oz ready-to-feed formula for the long-term management of premature infants with BPD who require severe fluid restriction.
